Clinical Trials in San Francisco

Showing 6341-6360 of 12,991 trials

A Study of Venetoclax in Combination With Cobimetinib and Venetoclax in Combination With Idasanutlin in Patients With Relapsed or Refractory Acute Myeloid Leukemia Who Are Not Eligible for Cytotoxic Therapy

NCT02670044

The primary objective for this study is to assess the safety and tolerability as well as preliminary efficacy of venetoclax in combination with cobimetinib, and venetoclax in combination with idasanutlin in patients with relapsed or refractory acute myeloid leukemia (R/R) AML who are not eligible for cytotoxic therapy.

Leukemia, Myeloid, Acute

Hoffmann-La Roche88 participantsStarted Mar 2016

Los Angeles, California, United States • Sacramento, California, United States • San Francisco, California, United States +14 more locations

TERMINATEDPhase 2< 1 mile

Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

NCT03370120

The purpose of the study is to evaluate the long-term safety and tolerability of Padsevonil administered at individualized doses as adjunctive treatment for subjects with drug-resistant epilepsy.

Drug-Resistant EpilepsyFocal-Onset Seizures

UCB Biopharma SRL406 participantsStarted Aug 2018

Chandler, Arizona, United States • La Jolla, California, United States • San Francisco, California, United States +153 more locations

A Study of Venetoclax in Combination With Cobimetinib and Venetoclax in Combination With Idasanutlin in Patients With Relapsed or Refractory Acute Myeloid Leukemia Who Are Not Eligible for Cytotoxic Therapy

Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

Find Trials by Condition in San Francisco

Kaiser Permanente Evaluation of Medically Tailored Meals in Adults With Medical Conditions at High Readmission Risk

Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders

A Study Evaluating the Efficacy and Safety of AG-348 in Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD)

Cognoa ASD Diagnosis Aid Validation Study

A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)

Efficacy Study of Preconception Treatment of an Asymptomatic Bacterial Infection in an Infertility Population

A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes

The RE-ENERGIZE Study: RandomizEd Trial of ENtERal Glutamine to minimIZE Thermal Injury

Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03

A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)

Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva

A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

T-Guard as Treatment for Steroid Refractory Acute GVHD (BMT CTN 1802)

Deep Phenotyping in Patients With ALS

Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease